• Ki-67
  • Primary pulmonary hypertension
  • Amyloid Protein Identification
  • Biopsy, Brain
  • 6-Monoacetylmorphine (6-MAM) Confirmation, Meconium
  • Interferon Lambda 3 (IFNL3) Gene Mutation Analysis
  • Kallmann Syndrome, Xp22.3 Deletion, FISH
  • Duloxetine, Urine
  • Levodopa, Serum
  • Alveolar Rhabdomyosarcoma (ARMS), 13q14 (FOXO1 or FKHR) Rearrangement, FISH, Tissue
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G Polymorphism
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G Polymorphism
Medical Test

Clinical Utility
Access to Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G Polymorphism is restricted.